← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1995Last known activity
Jul 1, 2025
Timeline
1950s
- Oct 20, 1955
German Federal Ministry of Education and Research— Founded
Drugs by trial phase (146 distinct, 95 trials)
Phase 4 (45 own, 0 via acquisition)
Phase 3 (37 own, 0 via acquisition)
Phase 2 (39 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (22 own, 0 via acquisition)
Indications
Studied for
- Adrenocortical Carcinoma
- Agoraphobia
- Alcoholism
- Alzheimer Disease
- Amyloidosis
- Aphasia
- Asthma
- Bacterial Infections
- Carcinoma
- Carcinoma, Hepatocellular
- Cardiomyopathies
- Chronic Pain
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Complex Regional Pain Syndromes
- Coronary Artery Disease
- Coronary Disease
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diarrhea
- Eisenmenger Complex
- Embolism
- Familial Primary Pulmonary Hypertension
- Fibrosis
- Glioblastoma
- Granuloma
- Granulomatous Disease, Chronic
- Hyperalgesia
- Hypertension
- Infections
- Inflammatory Bowel Diseases
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Leishmaniasis
- Leishmaniasis, Cutaneous
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, Promyelocytic, Acute
- Liver Cirrhosis
- Lung Diseases
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Malaria
- Malaria, Falciparum
- Mental Disorders
- Metabolic Syndrome
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Mycobacterium Infections
- Myocardial Ischemia
- Nephritis, Hereditary
- Neuralgia
- Neuritis
- Optic Neuritis
- Osteoporosis
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prodromal Symptoms
- Psychotic Disorders
- Pulmonary Embolism
- Reflex Sympathetic Dystrophy
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Schizophrenia
- Sclerosis
- Sepsis
- Shock
- Shock, Septic
- Stroke
- Syndrome
- Tetralogy of Fallot
- Thrombosis
- Toxemia
- Tuberculosis
- Tuberculosis, Pulmonary
- Ulcer
- Venous Thromboembolism
- Venous Thrombosis
- Wounds and Injuries
Recent trials (50)
- NCT06845124CollaboratorPhase 2Jul 1, 2025
- NCT06938867CollaboratorPhase 1/Phase 2Feb 25, 2025
- NCT06488625CollaboratorPhase 2/Phase 3Sep 12, 2024
- NCT06414031CollaboratorPhase 3Jun 17, 2024
- NCT05959421CollaboratorPhase 3Feb 29, 2024
- NCT06155656CollaboratorN/ADec 15, 2023
- NCT06054035CollaboratorPhase 4Oct 15, 2023
- NCT06830421CollaboratorPhase 3Aug 9, 2023
- NCT06061094CollaboratorPhase 2Jul 14, 2023
- NCT04729582CollaboratorPhase 1/Phase 2Apr 30, 2022
- NCT05360953CollaboratorPhase 2Apr 6, 2022
- NCT05132920CollaboratorPhase 3Nov 30, 2021
- NCT05093296CollaboratorPhase 2/Phase 3Nov 1, 2021
- NCT04922827CollaboratorPhase 2Jun 18, 2021
- NCT04931368CollaboratorPhase 3Jun 7, 2021
Details
- Founded
- Bonn, DE Oct 20, 1955
- Last known activity
- Jul 1, 2025